We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

000009:SSEChina Baoan Group Co., Ltd. Analysis

Data as of 2026-03-17 - not real-time

CN¥9.28

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

China Baoan Group is trading near the upper end of its recent range at a price that sits just above the DCF‑derived fair value, while its trailing P/E is dramatically higher than the industry average, indicating a substantial premium. Revenue growth is robust at roughly 30% year‑over‑year, but profit margins remain thin and free cash flow is negative, raising concerns about earnings quality. The balance sheet carries a very high debt‑to‑equity ratio and a payout ratio exceeding 100%, suggesting dividend sustainability is questionable. Technically, the stock is below its 20‑day SMA and 50‑day SMA, signaling a bearish trend, yet the MACD has turned bullish and volume is rising, hinting at short‑term upside potential. The RSI sits near the midpoint, offering no clear overbought or oversold signal.
Given the extreme valuation disparity, the company’s diversified but capital‑intensive business model, and the heightened volatility observed over the past month, investors should approach with caution. The forward P/E of around ten points to an earnings recovery that could justify a moderate re‑rating, but the high leverage and weak cash generation temper enthusiasm. Overall, the stock appears priced for modest upside in the medium term, but long‑term prospects remain constrained by financial risk and sector dynamics.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish price trend relative to moving averages
  • Technical bullish crossover in MACD with rising volume
  • Overvaluation relative to fair value and industry peers

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Strong revenue growth and improving forward earnings outlook
  • Price approaching DCF fair value suggesting upside
  • Increasing trading activity indicating market interest

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • High leverage and negative free cash flow
  • Dividend payout exceeding earnings sustainability
  • Diversified but capital‑intensive business segments exposing regulatory and sector risk

Key Metrics & Analysis

Financial Health

Revenue Growth29.70%
Profit Margin0.32%
P/E Ratio309.3
ROE6.46%
ROA2.35%
Debt/Equity89.88
P/B Ratio2.4
Op. Cash FlowCN¥1.4B
Free Cash FlowCN¥-2905274112
Industry P/E29.3

Technical Analysis

TrendBearish
RSI46.4
SupportCN¥8.80
ResistanceCN¥9.80
MA 20CN¥9.32
MA 50CN¥9.72
MA 200CN¥9.77
MACDBullish
VolumeIncreasing
Fear & Greed Index79.45

Valuation

Fair ValueCN¥8.82
GradeOvervalued
TypeBlend
Dividend Yield0.32%

Risk Assessment

Beta0.11
Volatility31.58%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.